ALN-PNP
ALN-PNP-MASLD-2543
Phase 2 small_molecule active
Quick answer
ALN-PNP for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active